The Serum Industry: Its Past, Present, and Future
Axenia BioLogix is driving the van, responding to the needs of future life science professionals to know everything from the health and diet of the animals (from which serum becomes a by-product) to how it is processed, to every chemical element it contains. This “need to know” is a welcome phenomenon for some manufacturers and a wake-up call for others.
With a rich past, serum remains at the forefront of biomedicine
For more than 80 years, sera have been widely used in the production of vaccines for both human and animal applications and is responsible for a number of history’s scientific biomedical breakthroughs, saving millions of lives. As far back as the 1940s, the use of animal sera in growing cells in-vitro has been key in the development of biotechnology. The injectable polio vaccine, developed by Jonas Salk in the early 1950s, was one of the first biologics mass-produced using cell culture techniques and played a significant role in reducing infection rates amongst children.
Animal-derived components continue to be critical to the production of many health-care related products and have never been directly linked to adverse impacts in humans.